alexa Abstract | Efficacy of Clopidogrel Drug and Response Prediction with Special Reference to Recent Paradigm Shift

International Journal of Drug Development and Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

The role of clopidogrel in disruption of platelet aggregation is well known. The variability in clopidogrel response is a well-documented phenomenon and has been widely addressed through pharmacogenomics. CYP2C19 has been considered as genetic predictor of clopidogrel response. Owing to the inter-individual variations, CPIC (Clinical Pharmacogenetics Implementation Consortium) had issued guidelines in compliance with FDA. However, based on the genetic proofs clinical utility is more or less unsuccessful. The use of miRNAs to predict drug response and the introduction of miRNA-pharmacogenomics holds promise to bridge this gap and may improves the clinical utility by synergistically addressing the issue through genetic variations and miRNAs.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Anu Radha Sharma and Padmalatha S Rai

Keywords

Clopidogrel, Pharmacogenomics, miRNA pharmacogenomics, Genetic variations, Drug Development and Drug Research

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us